| 1 | HIC1, LCN2
|
| HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2.
|
| Cheng G, Sun X, Wang J, Xiao G, Wang X, Fan X, Zu L, Hao M, Qu Q, Mao Y, Xue Y, Wang J.
|
| Cancer Res 74(3):862-72. doi: 10.1158/0008-5472.CAN-13-2420. Epub 2013 Dec 2.
2014
|
| 2 | LCN2
|
| Secreted protein lipocalin-2 promotes microglial M1 polarization.
|
| Jang E, Lee S, Kim JH, Kim JH, Seo JW, Lee WH, Mori K, Nakao K, Suk K.
|
| FASEB J 27(3):1176-90. doi: 10.1096/fj.12-222257. Epub 2012 Dec 3.
2013
|
| 3 | LCN2
|
| Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer.
|
| Yang J, McNeish B, Butterfield C, Moses MA.
|
| FASEB J 27(1):45-50. doi: 10.1096/fj.12-211730. Epub 2012 Sep 14.
2013
|
| 4 | LCN2, STEAP4
|
| Six-transmembrane epithelial antigen of prostate 4 and neutrophil gelatinase-associated lipocalin expression in visceral adipose tissue is related to iron status and inflammation in human obesity.
|
| Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Rotellar F, Valentí V, Silva C, Gil MJ, Salvador J, Frühbeck G.
|
| Eur J Nutr 52(6):1587-95. doi: 10.1007/s00394-012-0464-8. Epub 2012 Nov 22.
2013
|
| 5 | LCN2
|
| Regulation by lipocalin-2 of neuronal cell death, migration, and morphology.
|
| Lee S, Lee WH, Lee MS, Mori K, Suk K.
|
| J Neurosci Res 90(3):540-50. doi: 10.1002/jnr.22779. Epub 2011 Oct 31.
2012
|
| 6 | LCN2
|
| Lipocalin-2 ameliorates granulocyte functionality.
|
| Schroll A, Eller K, Feistritzer C, Nairz M, Sonnweber T, Moser PA, Rosenkranz AR, Theurl I, Weiss G.
|
| Eur J Immunol 42(12):3346-57. doi: 10.1002/eji.201142351. Epub 2012 Nov 7.
2012
|
| 7 | DDIT3, LCN2
|
| Lipocalin 2, a new GADD153 target gene, as an apoptosis inducer of endoplasmic reticulum stress in lung cancer cells.
|
| Hsin IL, Hsiao YC, Wu MF, Jan MS, Tang SC, Lin YW, Hsu CP, Ko JL.
|
| Toxicol Appl Pharmacol 263(3):330-7. doi: 10.1016/j.taap.2012.07.005. Epub 2012 Jul 16.
2012
|
| 8 | LCN2
|
| Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease.
|
| Naudé PJ, Nyakas C, Eiden LE, Ait-Ali D, van der Heide R, Engelborghs S, Luiten PG, De Deyn PP, den Boer JA, Eisel UL.
|
| FASEB J 26(7):2811-23. doi: 10.1096/fj.11-202457. Epub 2012 Mar 21.
2012
|
| 9 | LCN2
|
| Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation.
|
| Xu G, Ahn J, Chang S, Eguchi M, Ogier A, Han S, Park Y, Shim C, Jang Y, Yang B, Xu A, Wang Y, Sweeney G.
|
| J Biol Chem 287(7):4808-17. doi: 10.1074/jbc.M111.275719. Epub 2011 Nov 22.
2012
|
| 10 | LCN2, SLC22A17
|
| Lipocalin-2 (24p3/neutrophil gelatinase-associated lipocalin (NGAL)) receptor is expressed in distal nephron and mediates protein endocytosis.
|
| Langelueddecke C, Roussa E, Fenton RA, Wolff NA, Lee WK, Thévenod F.
|
| J Biol Chem 287(1):159-69. doi: 10.1074/jbc.M111.308296. Epub 2011 Nov 14.
2012
|
| 11 | LCN2, SLC22A17
|
| Expression of NGAL and NGALR in human embryonic, fetal and normal adult tissues.
|
| Zhang PX, Zhang FR, Xie JJ, Tao LH, Lü Z, Xu XE, Shen J, Xu LY, Li EM.
|
| Mol Med Rep 6(4):716-22. doi: 10.3892/mmr.2012.980. Epub 2012 Jul 6.
2012
|
| 12 | CXCL10, LCN2
|
| Lipocalin-2 Is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration.
|
| Lee S, Kim JH, Kim JH, Seo JW, Han HS, Lee WH, Mori K, Nakao K, Barasch J, Suk K.
|
| J Biol Chem 286(51):43855-70. doi: 10.1074/jbc.M111.299248. Epub 2011 Oct 26.
2011
|
| 13 | LCN2
|
| Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation.
|
| Mucha M, Skrzypiec AE, Schiavon E, Attwood BK, Kucerova E, Pawlak R.
|
| Proc Natl Acad Sci U S A 108(45):18436-41. doi: 10.1073/pnas.1107936108. Epub 2011 Oct 3.
2011
|
| 14 | LCN2
|
| Increased plasma levels of lipocalin 2 in mild cognitive impairment.
|
| Choi J, Lee HW, Suk K.
|
| J Neurol Sci 305(1-2):28-33. doi: 10.1016/j.jns.2011.03.023. Epub 2011 Apr 3.
2011
|
| 15 | LCN2
|
| Lipocalin 2 deficiency inhibits cell proliferation, autophagy, and mitochondrial biogenesis in mouse embryonic cells.
|
| Jin D, Zhang Y, Chen X.
|
| Mol Cell Biochem 351(1-2):165-72. doi: 10.1007/s11010-011-0724-6. Epub 2011 Jan 14.
2011
|
| 16 | LCN2
|
| Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure.
|
| Jin D, Guo H, Bu SY, Zhang Y, Hannaford J, Mashek DG, Chen X.
|
| FASEB J 25(2):754-64. doi: 10.1096/fj.10-165175. Epub 2010 Oct 25.
2011
|
| 17 | LCN2, SLC22A17
|
| Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma.
|
| Miyamoto T, Asaka R, Suzuki A, Takatsu A, Kashima H, Shiozawa T.
|
| Exp Mol Pathol 91(2):563-8. doi: 10.1016/j.yexmp.2011.06.002. Epub 2011 Jul 8.
2011
|
| 18 | LCN2, SLC22A17
|
| NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis.
|
| Liu MF, Jin T, Shen JH, Shen ZY, Zheng ZC, Zhang ZL, Xu LY, Li EM, Xu HX.
|
| J Neurooncol 104(1):119-27. doi: 10.1007/s11060-010-0486-0. Epub 2010 Dec 24.
2011
|
| 19 | LCN2, NFATC4
|
| NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene.
|
| Fougère M, Gaudineau B, Barbier J, Guaddachi F, Feugeas JP, Auboeuf D, Jauliac S.
|
| Oncogene 29(15):2292-301. Epub 2010 Jan 25.PMID: 20101218 2010
|
| 20 | LCN2
|
| Lipocalin 2 promotes breast cancer progression.
|
| Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, Strong RK, Zurakowski D, Moses MA.
|
| Proc Natl Acad Sci U S A 106(10):3913-8. Epub 2009 Feb 23.
2009
|
| 21 | LCN2
|
| Lipocalin 2 is required for pulmonary host defense against Klebsiella infection.
|
| Chan YR, Liu JS, Pociask DA, Zheng M, Mietzner TA, Berger T, Mak TW, Clifton MC, Strong RK, Ray P, Kolls JK.
|
| J Immunol 182(8):4947-56.
2009
|
| 22 | LCN2, LRP2, SLC22A17
|
| Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells.
|
| Miharada K, Hiroyama T, Sudo K, Danjo I, Nagasawa T, Nakamura Y.
|
| J Cell Physiol 215(2):526-37. 2008
|
| 23 | LCN2
|
| Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.
|
| Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, Harikumar KB, Ramachandran V, Sung B, Chakraborty A, Bresalier RS, Logsdon C, Aggarwal BB, Krishnan S, Guha S.
|
| Cancer Res 68(15):6100-8.
2008
|
| 24 | LCN2
|
| Lipocalin 2 is required for BCR-ABL-induced tumorigenesis.
|
| Leng X, Lin H, Ding T, Wang Y, Wu Y, Klumpp S, Sun T, Zhou Y, Monaco P, Belmont J, Aderem A, Akira S, Strong R, Arlinghaus R.
|
| Oncogene 27(47):6110-9. Epub 2008 Jul 28.
2008
|
| 25 | LCN2
|
| Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
|
| Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M.
|
| Kidney Blood Press Res 31(4):255-8. Epub 2008 Jul 5.
2008
|
| 26 | LCN2
|
| The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages.
|
| Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, Chen X.
|
| Mol Endocrinol 22(6):1416-26. Epub 2008 Feb 21.PMID: 18292240 2008
|
| 27 | LCN2
|
| Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA.
|
| Stejskal D, Karpísek M, Humenanska V, Hanulova Z, Stejskal P, Kusnierova P, Petzel M.
|
| Horm Metab Res 40(6):381-5. Epub 2008 Mar 31.
2008
|
| 28 | LCN2, SLC22A17
|
| A novel alternative spliced variant of neutrophil gelatinase-associated lipocalin receptor in oesophageal carcinoma cells.
|
| Fang WK, Xu LY, Lu XF, Liao LD, Cai WJ, Shen ZY, Li EM.
|
| Biochem J 403(2):297-303.
2007
|
| 29 | LCN2
|
| Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells.
|
| Hanai J, Mammoto T, Seth P, Mori K, Karumanchi SA, Barasch J, Sukhatme VP.
|
| J Biol Chem 280(14):13641-7. Epub 2005 Feb 3. 2005
|
| 30 | CD74, DEFA5, DEFA6, ESD, CXCL1, IGHG3, IGLL2, LCN2, REG3A, PI3, REG1A, S100A9, S100P
|
| Ulcerative colitis and Crohn's disease : distinctive gene expression profiles and novel susceptibility candidate genes.
|
| Lawrance IC, Fiocchi C, Chakravarti S.
|
| Hum Mol Genet 10(5):445-56. 2001
|
| 31 | LCN2
|
| Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation.
|
| Devireddy LR, Teodoro JG, Richard FA, Green MR.
|
| Science 293(5531):829-34. 2001
|
| 32 | LCN1, LCN2, OBP2A, OBP2B
|
| A novel human odorant-binding protein gene family resulting from genomic duplicons at 9q34: differential expression in the oral and genital spheres.
|
| Lacazette E, Gachon AM, Pitiot G.
|
| Hum Mol Genet 9(2):289-301 2000
|
| 33 | LCN2
|
| Heterogeneous expression of the lipocalin NGAL in primary breast cancers.
|
| Stoesz SP, et al.
|
| Int J Cancer 79 : 565-572. 1998
|
| 34 | LCN2
|
| Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans.
|
| Cowland JB, Borregaard N.
|
| Genomics 45(1):17-23. 1997
|
| 35 | AMBP, APOD, C8G, CRABP1, CRABP2, LCN1, LCN2, OBP2A, OBP2B, ORM1, ORM2, PAEP, PTGS1, PTGS2, RBP1, RBP2, RBP3, RBP4
|
| The lipocalin protein family: structure and function.
|
| Flower DR.
|
| Biochem J 318 ( Pt 1):1-14. Review 1996
|
| 36 | LCN2
|
| Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells.
|
| Bartsch S, et al.
|
| FEBS Lett 357 : 255-259. 1995
|
| 37 | C8G, LCN1, LCN2, PAEP, PTGS1
|
| Comparative mapping of lipocalin genes in human and mouse : the four genes for complement C8 gamma chain, prostaglandin-D- synthase, oncogene-24P3, and progestagen-associated endometrial protein map to HSA9 and MMU2.
|
| Chan P, et al.
|
| Genomics 23 : 145-150. 1994
|
| 38 | LCN2
|
| Molecular cloning and expression of a cDNA encoding NGAL : a lipocalin expressed in human neutrophils.
|
| Bundgaard JR, et al.
|
| Biochem Biophys Res Commun 202 : 1468-1475. 1994
|